baber/WOPTO huggingface dataset:
Patent FI-953490-A0 (FI)
Inventor: FENTON JOHN CHARLES
IPC: D01F9/04
Filed: 1995-07-19
Abstract: PCT No. PCT/GB94/00102 Sec. 371 Date Sep. 15, 1995 Sec. 102(e) Date Sep. 15, 1995 PCT Filed Jan. 19, 1994 PCT Pub. No. WO94/17227 PCT Pub. Date Aug. 4, 1994Highly absorbent alginate fibers are described which have use in the manufacture of dressings. The fibers and dressings described are highly swellable while also being soluble, rather than just being soluble. This is a considerable advantage for use in environments where high absorption coupled with biodegradability is desired, for example, in wound dressings such as dressings for ulcers or burns.
Patent FI-955307-A0 (FI)
Inventor: HOLTEY THOMAS O
IPC: G07F7/10
Filed: 1995-11-06
Abstract: A secure memory card includes a microprocessor on a single semiconductor chip and one or more non-volatile addressable memory chips. The microprocessor chip and non-volatile memory chips connect in common to an internal card bus for transmitting address, data and control information to such non-volatile memory chips. The microprocessor includes an addressable non-volatile memory for storing information including a number of key values, application specific configuration information and program instruction information. Each chip's memory is organized into a number of blocks or banks and each memory chip is constructed to include security control logic circuits. These circuits include a number of non-volatile and volatile memory devices of which are loaded with key and configuration information under the control of the microprocessor only after the microprocessor has determined that the user has successfully performed a predetermined authentication procedure with a host computer. Thereafter, the user is allowed to read out information from blocks only as defined by the configuration information. <IMAGE>
Patent FI-960825-A0 (FI)
Inventor: BRINKMEYER FRANCIS M
IPC: B01D3/42
Filed: 1996-02-23
Abstract: In a process for manufacture of a chemical product in which a plurality of individual reactant containing feedstreams are combined to form a mixed feedstream for a reactor, and wherein at least one of the plurality of feedstreams is subject to variations in reactant concentration, and another one of the plurality of feedstreams is essentially stable in reactant concentration, a desired ratio of relative reactant concentrations in the mixed feedstream is maintained by a control system which infers a reactant concentration ratio in the mixed feedstream based on process measurements and feed parameters related to the plurality of feedstock containing streams prior to their being combined. In use, flow rate of the feedstream which is essentially stable in reactant concentration is manipulated to maintain the inferred reactant concentrations in the mixed stream.   <IMAGE>
Patent FI-970817-A0 (FI)
Inventor: PASSI JOUKO
IPC: E06B7/082
Filed: 1997-02-27
Abstract: In a method for supporting wood pieces (1) with at least one fixing means (4), the wood piece (1) is formed as a structure comprising at least two walls (1a, 1b, 1d) and a bottom part (1c) in its cross-sectional profile form, wherein the outermost walls (1a, 1b) and the bottom part (1c) of the wood piece (1) limit an inner volume (2). The wood piece (1) is supported on at least one wall (1a, 1b, 1c) on the range of three quarters of the height of the inner volume (2) located closest to the bottom part (1c) in the cross-sectional profile form, advantageously in the range between the midpoint of the height of the inner volume (2) and the bottom part (1c), preferably in the range of that quarter of the height of the inner volume (2) which is placed closest to the bottom part (1c) of the wood piece (1) in the cross-sectional profile form.
Patent FI-982148-A0 (FI)
Inventor: HURSKAINEN AARNE
IPC: B05B3/02
Filed: 1998-10-05
Abstract: A method and apparatus for process washing of a process device is provided. The process washing apparatus includes a washing device that moves inside the process device. A washing medium of the washing device is led at least partly inside a body of the washing device in order to lead the washing medium to a target. The washing medium is sprayed to the target by nozzles disposed in the body of the washing device. The apparatus includes first and second supply assemblies for supplying the washing medium to the nozzles. Flow of the washing medium to the first supply assembly is controlled independently of flow of the washing medium to the second supply assembly, and the supply assemblies are capable of moving independently of one another. A method of operating the apparatus including controlling the flow of the washing medium and moving the supply assemblies independently of each other is disclosed.
Patent FI-990844-A0 (FI)
Inventor: USKELA SAMI
IPC: H04W8/22
Filed: 1999-04-15
Abstract: Users in a telecommunication system will probably change every now and then the mobile terminals they are using. A new mobile terminal does not necessarily comprise the service components that are required by the services the user has subscribed. In the arrangements according to the invention, service components provided in a mobile terminal are compared (303) with the components required in the services the subscriber has subscribed to, and if a service component is missing from the mobile terminal, a procedure for loading the component is activated. In this manner the mobile terminal can be provided with the services the user has subscribed to without the user having to be aware of the service components that are provided and required in the mobile terminal.
Patent IL-68833-A0 (IL)
Title: (+)-cyanidan-3-ol derivatives,their manufacture and pharmaceutical compositions containing them
IPC: A61P35/00
Filed: 1983-05-31
Abstract: Compound of the formula <CHEM>  in which R and R min  represent hydrogen or an optionally substituted hydrocarbon radical or acyl radical, R1 represents hydrogen or an optionally substituted hydrocarbon radical of aliphatic or aromatic character, R2 represents hydrogen or an optionally substituted hydrocarbon radical of higher aliphatic or aromatic character,  it being possible for R1 and R2 together to represent also an optionally substituted alkylene radikal or an optionally substituted biphenyl-2,2 min -ylene radical, whereby however, when R, R1 and R2 are hydrogen, R min  cannot be methyl and salts of such compounds that contain a saltforming grouping, and pharmaceutical compositions containing these compounds.   The pharmaceutical compositions containing these compounds are particularly valuable for treating liver and venous diseases.
Patent IL-84954-A0 (IL)
Title: Dioxalanes and thio analogs,derivatives thereof and lubricants and fuels containing same
IPC: C07D339/06
Filed: 1987-12-28
Abstract: Dioxolanes, thio analogs thereof, and derivatives of these and methods of preparation are described. These materials are useful as additives in lubricants and fuels. Methods for reducing fuel consumption in internal combustion engines employing the lubricating compositions are described.
Patent IL-86237-A0 (IL)
Title: Coleopteran active microorganisms,related insecticide compositions and methods for their production and use
IPC: A01N63/50
Filed: 1988-05-01
Abstract: This invention relates to Bacillus thuringiensis strains that have insecticidal activity against lepidopteran and coleopteran insects, the coleopteran-active endotoxin being produced by an acquired plasmid. This invention also relates to the crystalline protein toxin useful as a biological insecticide against Coleoptera which toxin is produced by the strain of Bacillus thuringiensis. This invention also relates to the expression in various microorganisms of the gene, known as cryC, which codes for this toxin, and for related novel insecticide compositions and methods for their use.
Patent IL-87107-A0 (IL)
Title: Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/55
Filed: 1988-07-14
Abstract: A novel naphthpthiazepine derivative of the formula: <CHEM> wherein R<1> is a lower alkoxy group, R<2> is hydrogen atom or a lower alkanoyl group, and R<3> and R<4> are the same or different and hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable acid addition salt thereof, are disclosed. Said derivative (I) and a salt thereof are useful as hypotensive agents and/or coronary or cerebral vasodilators.
Patent IL-90248-A0 (IL)
Title: Container
IPC: B65D5/462
Filed: 1989-05-09
Abstract: A unit (3) for fitting on the open top of a container (1) made of cardboard, corrugated board or similar lightweight semi-rigid sheet material, said unit including securing means (10) arranged to be located and secured in an aperture (15) in a side wall of the container, spaced downwardly from the top thereof, to secure the unit to the container, the said securing means being arranged to extend through the said aperture and to protrude inwardly of the container wall, and being formed as a hollow element to define an outwardly opening but inwardly closed hand hole in the container wall, which hand hole is closed off from the container interior. In an alternative form the hand hole is not necessarily inwardly closed, but the securing member is locked in position.
Patent IL-95325-A0 (IL)
Title: 2-oxo-3,8-diazaspiro(4,5)decane derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/445
Filed: 1990-08-09
Abstract: 4,4-disubstd piperidine derivs of formula (I) and their acid addn and quaternary ammonium salts are new. In (I) R1 = H or C0NHR; R = H, 1-12C alkyl, 3-6C cycloalkyl or a carboxyclic 6-10C aryl or carbocycline (6-10C aryl) 1-4C alkyl opt ring substd by one or more halo, 1-4C alkyl or 1-4C alkoxy; R2 = ethynyl or C0CH3; Ph1 and Ph2 = phenyl opt substd by one or more halo, 1-4C alkyl, 1-4C alkoxy, trihalo or 0H opt esterified by a 1-4C alkansic acid; n = 1-2. - 3 Cpds (I) ie 1-(3,3-bis(4-fluorophenyl)-2-propenyl)-4 ethynyl-4-hydroxypiperidine hydrochloride, (Ib) 1-(4,4-bis(4-fluorophenyl)-3- butenyl)-4-ethynyl-4-hydroxy piperidine hydrochloride (Ia) and 1-(4,4-bis(4-fluorophenyl)-3- butenyl)-4-benzylcarbamoyloxy-4 ethynylpiperidine are specifically claimed.
Patent IL-95771-A0 (IL)
Title: Polyolefin compositions with improved impact strength
IPC: C08L33/04
Filed: 1990-09-25
Abstract: The addition of polyolefin-acrylic graft copolymer to blends of polyolefin and core-shell polymers improves compatibility and allows core-shell polymers to be used as processing and performance modifiers for polyolefins. A typical composition may contain about 20% core-shell modifier, about 10% compatibilizer, the balance being polyolefin and is suitable for making extruded, calendered or moulded products.
Patent IL-96049-A0 (IL)
Title: Preparation of pure,unsymetrically disubstituted ureas
IPC: C07C273/18
Filed: 1990-10-17
Abstract: Process for the preparation of pure, unsymmetrically disubstituted ureas of the general formula   <IMAGE> I  in which R denotes a phenyl radical which is unsubstituted, or monosubstituted or polysubstituted by halogen atoms or alkyl, alkoxy, aryloxy or trifluoromethyl groups, an oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, benzoxazolyl or benzothiazolyl radical which is unsubstituted, or monosubstituted or polysubstituted by halogen atoms or alkyl, alkoxy or trifluoromethyl groups and R1 and R2 independently of one another denote a hydrogen atom or an alkyl group, where R1 and R2 are not simultaneously hydrogen or R1 and R2 together denote a butylene or pentylene group, by reaction of an N-alkyl- or N,N-dialkylurea with an unsubstituted or substituted arylamine or a heterocyclic amine in the presence of that amine which is already present in the starting material, the respective N-alkyl- or N,N-dialkylurea.
Patent IL-97439-A0 (IL)
Title: 3-tetrazolylthiomethyl cephalosporin antibiotics
IPC: C07D501/36
Filed: 1991-03-05
Abstract: A compound of the formula (II): <CHEM> and pharmaceutically acceptable salts and in vivo hydrolysable esters are described as is their preparation and use as antibacterial agents.
Patent IL-98456-A0 (IL)
Title: Nucleic acid ligands
IPC: G01N33/566
Filed: 1991-06-11
Abstract: A new class of nucleic acid compounds, referred to as nucleic acid antibodies, have been shown to exist that have a specific binding affinity for three dimensional molecular targets. In a preferred embodiment the ligand components of the nucleic acid antibodies are identified by the method of the invention referred to as the Systematic Evolution of Ligands by Exponential Enrichment (SELEX), wherein a candidate mixture of nucleic acids are iteratively enriched in high affinity nucleic acids and amplified for further partitioning.
Patent FI-20065605-A0 (FI)
Inventor: HUOVIALA RAUNO
IPC: H04L41/00
Filed: 2006-09-28
Abstract: Wireless links used as backhauls for wireless access networks may be provided by an HSDPA, while hot spots for network access may be built using another radio technology, such as WLAN. There may be several end-user terminals simultaneously accessing the network through the hot spot. Information on the number of user terminals connected to a hot spot is found out, and the information is provided to a backhaul network. The backhaul network then allocates the backhaul network resources between the user terminals connected to the hot spot and the user terminals connected to the backhaul network such that the number of user terminals connected to the hot spot is taken into account.
Patent IL-100288-A0 (IL)
Title: Method and compositions containing certain triazoles to protect materials from fungal attack
IPC: B27K3/34
Filed: 1991-12-09
Abstract: Specific triazoles discovered to be useful as fungicides are:   1.  alpha -n-butyl - alpha -phenyl-1H-1,2,4-triazole-1-propanenitrile     2.  alpha , alpha -diphenyl-1H-1,2,4-triazole-1-propanenitrile 3.  alpha -benzyl- alpha -phenyl-1H-1,2,4-triazole-1-propanenitrile   4.  alpha -n-butyl- alpha -2-methoxyphenyl-1H-1,2,4-triazole-1-propanenitrile 5.  alpha -n-butyl- alpha -4-fluorophenyl-1H-1,2,4-triazole-1-propanenitrile 6.  alpha -phenyl- alpha -(2-phenylethyl)-1H-1,2,4-triazole-1-propanenitrile 7.  alpha -(4-fluorophenyl)- alpha -n-propyl-1H-1,2,4-triazole-1-propanenitrile 8.  alpha - [2-(4-chlorophenyl)ethyl]- alpha -phenyl-1H-1,2,4-triazole-1- propanenitrile 9.  alpha -n-butyl- alpha -4-chlorophenyl-1H-1,2,4-triazole-1-propanenitrile   The materials which the fungicidal triazoles are capable of protecting include, for example, wood, fabric, leather, coatings, and caulks. Especially when wood is being protected from attack by fungi we prefer compositions comprising the triazole(s) and a quaternary ammonium compound
Patent IL-104986-A0 (IL)
Title: Topical preparations containing as active ingredient toremifene or one of its metabolites
IPC: A61K9/70
Filed: 1993-03-09
Abstract: PCT No. PCT/FI93/00119 Sec. 371 Date Oct. 31, 1994 Sec. 102(e) Date Oct. 31, 1994 PCT Filed Mar. 25, 1993 PCT Pub. No. WO93/19746 PCT Pub. Date Oct. 14, 1993Transdermal preparations containing as active ingredient toremifene or one of its metabolites N-demethyltoremifene or 4-hydroxy-toremifene or their pharmaceutically acceptable non-toxic salts are useful for the treatment of cancers localized in the skin or on a short distance form the skin such as metastatic lesions of breast cancer. They may also be used in adjuvant therapy of breast cancer and in the reversal of multidrug resistance of cancer cells to cytotoxic drugs. Such transdernal preparations are of particular interest in the treatment of melanoma, lymphoma, Kaposi's sarcoma and fungoides mycosis.
Patent IL-107134-A0 (IL)
Title: Pharmaceutical compositions for the treatment of parkinson's disease
IPC: A61K45/06
Filed: 1993-09-28
Abstract: The neuropsychiatric symptom of bradyphrenia in a Parkinson's Disease patient may be ameliorated by treating the patient with a histamine H2-antagonist that passes the blood brain barrier. Suitable H2-antagonists include famotidine and ranitidine. The H2-antagonists may be co-administered with other compounds such as histamine H1-antagonists which are known to be useful in the treatment of Parkinson's Disease, and can be formulated with such other compounds into a therapeutic composition.
Patent IL-109526-A0 (IL)
Title: Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IPC: C07D413/06
Filed: 1994-05-03
Abstract: The benzofuranyl- and -thiophenyl-alkane-carboxylic acid derivatives of the formula (I) <CHEM> wherein R1, R2, R3, T, V, and W are as defined in Claim 1 are prepared by cyclisation of hydroxy acetophenones and related compounds or by Wittig-reaction of benzofuranyl aldehydes. The compounds can be used to prepare medicaments showing antiinflammatory activity.
Patent IL-109609-A0 (IL)
Title: A communication device for computer networks of the cordless type
IPC: H04B1/40
Filed: 1994-05-10
Abstract: PCT No. PCT/EP94/01426 Sec. 371 Date Oct. 27, 1995 Sec. 102(e) Date Oct. 27, 1995 PCT Filed May 5, 1994 PCT Pub. No. WO94/27392 PCT Pub. Date Nov. 24, 1994A communication device (1) for computer local networks of the cordless type uses a modulator (MOD) able to perform FSK modulation on the data (DDI) to be transmitted, with optimum characteristics thanks to a digital switch (SW) controlled by the data (DDI) which commutes during transmission between two fixed frequencies received from a quartz oscillator, in association with a filter of the surface acoustic wave type (SAW). The device (1) permits a significant improvement in circuit integration and is simple and of low cost.
Patent IL-111077-A0 (IL)
Title: Pharmacologically active pyridine derivatives and processes for the preparation thereof
IPC: A61P17/00
Filed: 1994-09-29
Abstract: PCT No. PCT/EP94/03151 Sec. 371 Date May 31, 1995 Sec. 102(e) Date May 31, 1995 PCT Filed Sep. 21, 1994 PCT Pub. No. WO95/09853 PCT Pub. Date Apr. 13, 1993N-phenyl-2-pyrimidineamine derivatives of formula I    <IMAGE>  (I)  wherein the substituents are as defined in claim 1 and the derivatives of formula I can be used, for example, in the treatment of tumour diseases.
Patent IL-115920-A0 (IL)
Title: 2,2-dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
IPC: C07C53/16
Filed: 1995-11-08
Abstract: PCT No. PCT/EP95/04413 Sec. 371 Date Jul. 8, 1997 Sec. 102(e) Date Jul. 8, 1997 PCT Filed Nov. 9, 1995 PCT Pub. No. WO96/15784 PCT Pub. Date May 30, 1996Pharmaceutical agents for treating diabetus mellitus which contain a compound of formula I as the active substance, in which A, B, A' and W have the meanings stated in the claims, new compounds of formula I as well as processes for their production.
Patent IL-126044-A0 (IL)
Title: Engineering affinity ligands for macromolecules
IPC: G01N33/68
Filed: 1997-03-20
Abstract: A method is disclosed for obtaining highly specific and tailored ligands suitable for purifying a particular product target or for eliminating particular target impurities in a feed stream. Engineered affinity ligands according to the invention will bind a target with high specificity at a preselected binding condition and release the target at a preselected elution condition. The ligands are isolated by contacting a target with a multiplicity of polypeptides derived through variegation of the structure of a candidate binding domain, the variants (or analogues) including polypeptides favoring binding to the target under desired binding conditions and release from the target under elution conditions, where the binding and elution conditions differ according to one or more parameters, such as pH, temperature, concentration of salt or volume % of an organic solvent.
Patent IL-137997-A0 (IL)
Title: Dual diffuser assembly
IPC: C02F3/20
Filed: 1999-03-02
Abstract: The dual diffuser assembly of the present invention includes a first and second diffuser body in fluid communication with an air distribution pipe. The diffuser assembly further includes a saddle that connects the first diffuser body and the second diffuser body to the air distribution pipe. The air received from the distribution pipe passes into the first and second diffuser bodies and exits the first diffuser body through a first diffuser and exits the second diffuser body through a second diffuser. The first and second diffusers form the air into fine bubbles that serve to facilitate aeration of the medium.
Patent IL-140394-A0 (IL)
Title: A method for in vitro maturation of human gametes
IPC: G01N33/68
Filed: 1999-06-22
Abstract: <heading lvl="0">Abstract of Disclosure</heading> The present invention relates to a method for in vitro maturation of a human gamete by culturing an immature human gamete in a chemically defined cell culture medium. The human gamete can be a spermatocyte or an oocyte. The maturation end point is metaII. The advantage of the described medium is a synchronised cumulus-, cytoand nuclear maturation completed within a period of 20 to 30 hours. The medium should preferably contain ATA (Aurin Tri Carboxylicacid) as an anti-apototic agent. The medium should preferably not contain BSA, HSA or other directly serum derived products or substances.
Patent IL-146748-A0 (IL)
Title: Package for a pharmaceutical product and method of sterilising the package
IPC: B65D1/02
Filed: 2000-05-26
Abstract: A process for manufacturing a sterilized squeezable package of a pharmaceutical product, said package being a polypropylene bottle assembly which process comprises the steps: placing the package after having been filled with said pharmaceutical composition and closed, into an autoclaving chamber, adjusting the temperature and the pressure in said chamber as a function of time in accordance to the prerequisites of the material of said package, wherein a counter pressure is generated in said chamber and wherein this is regulated electronically via computer control, and wherein said counter pressure avoids a deformation of said package so that said package shows after an autoclaving processing of at least 121  DEG C and for at least 20 minutes no deformation such as shrinkage or blowing-up and retains a sufficient high squeezability in order to dispense said product.
Patent IL-149738-A0 (IL)
Title: Transverse ultrasound peening of blades on a rotor
IPC: F01D5/28
Filed: 2001-09-20
Abstract: A method, and machine for implementing the method, for transverse ultrasound peening of blades on a rotor that drives in rotation a wheel bearing the blades about its geometrical axis arranged substantially vertically and causes the blades to pass through a mist of microbeads produced by a vibrating surface in an active chamber arranged laterally relative to the wheel. The active surface is located beneath the path of the blades. Preferably, the active chamber includes a second vibrating surface above the path of the blades.